Mirasol PRT System inactivation efficacy evaluated in platelet concentrates by bacteria-contamination model;Ocena efikasnosti inaktivacije bakterija pomoću Mirasol PRT sistema u koncentrovanim trombocitima primenom modela bakterijske kontaminacije

Vojnosanitetski Pregled

Volumn 68, Issue 12, 2011, Pages 1041-1046

  Jocić, Miodrag ^a   Trkuljić, Miroljub ^a   Jovičić, Dragana ^a   Borovčanin, Nemanja ^a   Todorović, Milena ^b   Balint, Bela ^a,c  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Bacterial infections; Blood platelets; Platelet transfusion; Riboflavin; Treatment outcome; Ultraviolet rays

Indexed keywords

RIBOFLAVIN; THROMBOCYTE CONCENTRATE;

ARTICLE; ASEPSIS; BACTERIAL COUNT; BACTERIUM CONTAMINATION; BLOOD COMPONENT THERAPY; BLOOD GROUP ABO SYSTEM; CLINICAL EFFECTIVENESS; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; INFECTION CONTROL; MEDICAL INSTRUMENTATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTE; ULTRAVIOLET RADIATION;

BACTERIAL INFECTIONS; BLOOD PLATELETS; ESCHERICHIA COLI; HUMANS; PLATELET TRANSFUSION; STAPHYLOCOCCUS; ULTRAVIOLET RAYS;

EID: 82955165136     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1112041J     Document Type: Article

References (38)

1. Goodrich RP, Edrich RA, Li J, Seghatchian J. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006; 35(1): 5-17.
2. Goodrich RP, Doane S, Reddy HL. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010; 38(1): 20-30.
3. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 2008; 22(2): 133-53.
4. Goodrich P, Gilmour D, Hovenga N, Keil SD. A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion 2009; 49(6): 1205-16.
5. Solheim BG. Pathogen reduction of blood components. Transfus Apher Sci 2008; 39(1): 75-82.
6. Blajchman MA. Incidence and significance of the bacterial contamination of blood components. Dev Biol (Basel) 2002; 108: 59-67.
7. Brecher ME, Hay SN. Improving platelet safety: bacterial contamination of platelets. Curr Hematol Rep 2004; 3(2): 121-7.
8. Bueno JL. Skin disinfection and bacterial contamination of blood components: be simple. Transfusion 2010; 50(1): 5-8.
9. Goldman M, Roy G, Fréchette N, Décary F, Massicotte L, Delage G. Evaluation of donor skin disinfection methods. Transfusion 1997; 37(3): 309-12.
10. Lee CK, Ho PL, Chan NK, Mak A, Hong J, Lin CK. Impact of donor arm skin disinfection on the bacterial contamination rate of platelet concentrates. Vox Sang 2002; 83(3): 204-8.
11. McDonald CP, Lowe P, Roy A, Robbins S, Hartley S, Harrison JF, et al. Evaluation of donor arm disinfection techniques. Vox Sang 2001; 80(3): 135-41.
12. Tipple MA, Bland A, Murphy JJ, Arduino MJ, Panlilio AL, Farmer JJ 3rd, et al. Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica. Transfusion 1990; 30(3): 207-13.
13. Benavides S, Nicol K, Koranyi K, Nahata MC. Yersinia septic shock following an autologous transfusion in a pediatric patient. Transfus Apher Sci 2003; 28(1): 19-23.
14. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006; 20(4): 273-82.
15. Jafari M, Forsberg J, Gilcher RO, Smith JW, Crutcher JM, McDermott M, et al. Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake. N Engl J Med 2002; 347(14): 1075-8.
16. Heltberg O, Skov F, Gerner-Smidt P, Kolmos HJ, Dybkjaer E, Gutschik E, et al. Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion 1993; 33(3): 221-7.
17. Högman CF, Fritz H, Sandberg L. Posttransfusion Serratia marcescens septicemia. Transfusion 1993; 33(3): 189-91.
18. AuBuchon JP, Pickard C, Herschel L. Sterility of plastic tubing welds in components stored at room temperature. Transfusion 1995; 35(4): 303-7.
19. Loukhmas L, Houmane N, Mskine M, Mdaghri N, Benbachir M, Benchemsi N. Prevalence of bacterial contamination of standard platelet units: prospective study. Transfus Clin Biol 2000; 7(2): 171-6.
20. Brecher ME, Holland PV, Pineda AA, Tegtmeier GE, Yomtovian R. Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage. Transfusion 2000; 40(11): 1308-12.
21. McDonald CP, Roy A, Lowe P, Robbins S, Hartley S, Barbara JA. Evaluation of the BacT/Alert automated blood culture system for detecting bacteria and measuring their growth kinetics in leucodepleted and non-leucodepleted platelet concentrates. Vox Sang 2001; 81(3): 154-60.
22. Wagner SJ, Moroff G, Katz AJ, Friedman LI. Comparison of bacteria growth in single and pooled platelet concentrates after deliberate inoculation and storage. Transfusion 1995; 35(4): 298-302.
23. Germain M, Goldman M. Blood donor selection and screening: strategies to reduce recipient risk. Am J Ther 2002; 9(5): 406-10.
24. de Korte D, Marcelis JH, Soeterboek AM. Determination of the degree of bacterial contamination of whole-blood collections using an automated microbe-detection system. Transfusion 2001; 41(6): 815-8.
25. de Korte D, Marcelis JH, Verhoeven AJ, Soeterboek AM. Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections. Vox Sang 2002; 83(1): 13-6.
26. McDonald CP, Roy A, Mahajan P, Smith R, Charlett A, Barbara JA. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004; 86(3): 178-82.
27. McDonald C, McGuane S, Thomas J, Hartley S, Robbins S, Roy A, et al. A novel rapid and effective donor arm disinfection method. Transfusion 2010; 50(1): 53-8.
28. Pietersz RN, de Korte D, Reesink HW, Dekker WJ, van den Ende A, Loos JA. Storage of whole blood for up to 24 hours at ambient temperature prior to component preparation. Vox Sang 1989; 56(3): 145-50.
29. Wagner SJ, Robinette D, Nazario M, Moroff G. Bacteria levels in components prepared from deliberately inoculated whole blood held for 8 or 24 hours at 20 to 24 degrees C. Transfusion 1995; 35(11): 911-6.
30. Balint B, Stamatovic D. Clinical indications of transfusion therapy in internal medicine. In: Walterova L, Kretschmer V, Bogdanovic G, Rossi U, editors. The contribution of clinical medicine to blood safety. Procedings of the European School of Transfusional Medicine ESTM Residential Course Milano: ESTM; 2003. p. 51-60.
31. Lozano M, Cid J. Consensus and controversies in platelet transfusion: trigger for indication, and platelet dose. Transfus Clin Biol 2007; 14(6): 504-8
32. Pelletier JP, Transue S, Snyder EL. Pathogen inactivation techniques. Best Pract Res Clin Haematol 2006; 19(1): 205-42.
33. Blajchman MA. Bacterial contamination of cellular blood components: risks, sources and control. Vox Sang 2004; 87(Suppl 1): 98-103.
34. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005; 18(1): 195-204.
35. Ness P, Braine H, King K, Barrassso C, Kickler T, Fuller A, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001; 41(7): 857-61.
36. Rentas F, Harman R, Gomez C, Salata J, Childs J, Silva T, et al. Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion 2007; 47(2): 240-7.
37. Engelfriet CP, Reesink HW, Blajchman MA, Muylle L, Kjeldsen-Kragh J, Kekomaki R, et al. Bacterial contamination of blood components. Vox Sang 2000; 78(1): 59-67.
38. Ruane P, Edrich R, Gampp D, Keil S, Leonard L, Goodrich R. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44(6): 877-85.